New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...
The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...
The first draft guidance provides an initial framework for how the agency will assess AI models in drug development, but the ...
In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued ...
Trained on large databases of brain data among newborns, CergenX’s Wave device uses AI to help with earlier detection of ...
AI is touching every industry, and healthcare is no exception: the global market size for healthcare AI, which was valued at ...
Despite the AI hype, the systems require consistent monitoring and staffing to put in place and maintain. The process can be ...
Irish neurotech company CergenX has received the Breakthrough Device Designation from the US FDA while being accepted into ...
Also, the FDA advises sponsors to begin discussions with the agency early on about the use of AI credibility assessment or of AI in drug development. The FDA said the guidance was developed based ...